Mustafa Shadi Rifaat Bashir, MD

Publications

Harrison, Stephen A., Mustafa R. Bashir, Cynthia D. Guy, Rong Zhou, Cynthia A. Moylan, Juan P. Frias, Naim Alkhouri, et al. “Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.” Lancet 394, no. 10213 (November 30, 2019): 2012–24. https://doi.org/10.1016/S0140-6736(19)32517-6.

PMID
31727409
Full Text

Carey, Elizabeth J., Jennifer C. Lai, Christopher Sonnenday, Elliot B. Tapper, Puneeta Tandon, Andres Duarte-Rojo, Michael A. Dunn, et al. “A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.” Hepatology 70, no. 5 (November 2019): 1816–29. https://doi.org/10.1002/hep.30828.

PMID
31220351
Full Text

Expert Panel on Gastrointestinal Imaging, Laura R., Kristin K. Porter, Atif Zaheer, Ihab R. Kamel, Jeanne M. Horowitz, Hina Arif-Tiwari, Twyla B. Bartel, et al. “ACR Appropriateness Criteria® Acute Pancreatitis.” J Am Coll Radiol 16, no. 11S (November 2019): S316–30. https://doi.org/10.1016/j.jacr.2019.05.017.

PMID
31685100
Full Text

Cheung, Amanda, Brent A. Neuschwander-Tetri, David E. Kleiner, Elmer Schabel, Mary Rinella, Stephen Harrison, Vlad Ratziu, et al. “Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum.” Hepatology 70, no. 5 (November 2019): 1841–55. https://doi.org/10.1002/hep.30672.

PMID
31034092
Full Text

Kleiner, David E., Elizabeth M. Brunt, Laura A. Wilson, Cynthia Behling, Cynthia Guy, Melissa Contos, Oscar Cummings, et al. “Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.” Jama Netw Open 2, no. 10 (October 2, 2019): e1912565. https://doi.org/10.1001/jamanetworkopen.2019.12565.

PMID
31584681
Full Text

Harrison, Stephen A., Mustafa Bashir, Jennifer Shim-Lopez, Ken Song, and Hubert Chen. “MET409, A SUSTAINED FXR AGONIST, DECREASED HEPATIC FAT AND IMPROVED LIVER FUNCTION WITHOUT RAISING LDL-C AFTER 28 DAYS IN NASH PATIENTS.” In Hepatology, 70:1257A-1257A. WILEY, 2019.

Scholars@Duke

Harrison, Stephen A., Dean Tai, Ya-Yun Ren, Rebecca A. Taub, and Mustafa Bashir. “STEATOSIS AND FIBROSIS MEASURED AS CONTINUOUS VARIABLES ON PAIRED, SERIAL LIVER BIOPSIES IN THE RESMETIROM (MGL-3196) 36-WEEK PHASE 2 NASH STUDY.” In Hepatology, 70:1263A-1263A. WILEY, 2019.

Scholars@Duke

Harrison, Stephen A., Mustafa Bashir, Sam Moussa, Rebecca A. Taub, Juan Pablo Frias, and Naim Alkhouri. “EFFECTS OF RESMETIROM (MGL-3196) ON HEPATIC FAT, LIPIDS, LIVER ENZYMES AND MARKERS OF LIVER FIBROSIS IN AN OPEN-LABEL 36-WEEK EXTENSION STUDY IN NASH PATIENTS.” In Hepatology, 70:169A-170A. WILEY, 2019.

Scholars@Duke

Zulfiqar, Maria, Claude B. Sirlin, Norihide Yoneda, Maxime Ronot, Elizabeth M. Hecht, Victoria Chernyak, Osamu Matsui, et al. “Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach.” J Magn Reson Imaging, August 16, 2019. https://doi.org/10.1002/jmri.26902.

PMID
31418986
Full Text

Zhong, Xiaodong, Brian M. Dale, Marcel D. Nickel, Stephan A. R. Kannengiesser, Berthold Kiefer, and Mustafa Bashir. “Improved accuracy of apparent diffusion coefficient quantification using a fully automatic noise bias compensation method: Preliminary evaluation in prostate diffusion weighted imaging.” J Magn Reson 305 (August 2019): 22–30. https://doi.org/10.1016/j.jmr.2019.05.007.

PMID
31158792
Full Text

Pages